APPRAISAL OF INTRADERMAL IMMUNISATION AGAINST HEPATITIS B
The LancetPublished 1 February 1987
A. J. Zuckerman
Citations43
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
La vaccination par doses faibles en injections intradermiques peut donner d'excellents resultats mais l'application sur une grande echelle pose encore des problemes.
Abstract
La vaccination par doses faibles en injections intradermiques peut donner d'excellents resultats mais l'application sur une grande echelle pose encore des problemes (efficacite moindre apres rappel, necessite d'un personnel experimente, danger d'une injection sous-cutanee inefficace)
Keywords
Immunology and MicrobiologyMedicine
Expanded Programme on Immunization
398 Citations2001George Kassianos, Original English
The LancetCLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINE
238 Citations1984Wolfgang Jilg, M. Schmidt +4 more
In the recombinant vaccine group the immune response developed more slowly during the early phase and seroconversion rates and mean anti-HBs levels were slightly lower in males; this probably reflects use of a lower dose of recombinant vaccines.
The LancetINTRADERMAL HEPATITIS B VIRUS VACCINE: IMMUNOGENICITY AND SIDE-EFFECTS IN ADULTS
86 Citations1983KirkD. Miller, MauritaM. Mulligan +3 more
Fourteen adult volunteers were given a series of three 0.1 ml intradermal doses of hepatitis B virus vaccine (Merck) and an antibody (anti-HBs) response was induced in 10 of 12 (83%) who were antibody negative at the start of the study.
The LancetMULTISITE INTRADERMAL ANTIRABIES VACCINATION
64 Citations1981KarlG Nicholson, Howard Prestage +3 more
The results suggest that in developing countries patients could be protected with small volumes of potent tissue-culture vaccine administered intradermally shortly after exposure.
Journal of Medical VirologyEvaluation of a reduced dose of hepatitis B vaccine administered intradermally
50 Citations1984G. Zoulek, B. Lorbeer +2 more
Intradermal inoculation of hepatitis B vaccine (HBsAg subtype adw) caused no side effects, but the vaccine was less immunogenic than following intramuscular administration, and does not offer a major advantage to the generally used intamuscular immunization.
VaccineIntradermal hepatitis B vaccination in an abbreviated schedule
41 Citations1986Neal A. Halsey, Earl J. Reppert +3 more
Two low-dose intradermal regimens for hepatitis B vaccination were compared with the standard 1 ml dose administered intramuscularly to healthy, 22-42 year old individuals to suggest that a shortened regimen of intrader mal vaccine may be effective in healthy adults.
The LancetVERY-LOW-DOSE HEPATITIS B VACCINE IN NEWBORN INFANTS: AN ECONOMIC OPTION FOR CONTROL IN ENDEMIC AREAS
33 Citations1987Christopher D. Moyes, Mary Dimitrakakis +3 more
Three 1 microgram or 2 micrograms doses of Merck, Sharp and Dohme plasma vaccine were given to 119 infants of mothers negative for antibody to hepatitis B surface antigen, suggesting that maternal antibody does not interfere with the infant's immune response to low doses of vaccine.